Literature DB >> 12412721

Parathyroid carcinosarcoma: a previously unreported entity.

Randall Nacamuli1, Gregory J Rumore, Gary Clark.   

Abstract

Parathyroid carcinoma is a rare disease. The first report of parathyroid carcinoma with sarcomatous differentiation is presented. A parathyroid mass measuring 6 x 8 x 9 cm was surgically excised from the left side of the neck in a 54-year-old man who had mild hypercalcemia. Light microscopic examination of the mass showed carcinoma with areas of rhabdomyosarcoma and chondrosarcoma. Immunohistochemical studies confirmed the light microscopic impression. Resolution of hypercalcemia followed excision of the mass, but multiple pulmonary and adrenal masses subsequently developed and led to the patient's death despite aggressive trials of chemotherapy with doxorubicin, ifosfamide, and cisplatin. The sarcomatous elements of the mass excised from this patient are presumed to represent aberrant cellular differentiation previously described in uterine and other tissue but not in parathyroid glands. Sarcomatous differentiation itself appears to be a poor prognostic factor in parathyroid carcinoma.

Entities:  

Mesh:

Year:  2002        PMID: 12412721

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  3 in total

1.  Parathyroid carcinoma: A rare case with mandibular brown tumor.

Authors:  Payam S Pahlavan; Marianne C Severin
Journal:  Wien Klin Wochenschr       Date:  2006-04       Impact factor: 1.704

2.  Parathyroid carcinoma with sarcomatoid differentiation: a case report and literature review.

Authors:  Liang Hu; Xiaojun Xie
Journal:  Diagn Pathol       Date:  2020-12-14       Impact factor: 2.644

3.  Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma-A Rare, Highly Malignant Subtype.

Authors:  Yongchao Yu; Yue Wang; Qingcheng Wu; Xuzi Zhao; Deshun Liu; Yongfu Zhao; Yuguo Li; Guangzhi Wang; Jingchao Xu; Junzhu Chen; Ning Zhang; Xiaofeng Tian
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-15       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.